Jakir Hossain, CEO of JNS Technologies, Visited Guangzhou Haicheng Pharmaceutical (HC Pharma)’s Yunnan Factory
Recently, Mr. Jakir Hossain, CEO of JNS Technologies, paid an official inspection visit to the Yunnan production base of Guangzhou Haicheng Pharmaceutical (HC Pharma). The visit aimed at gaining an in-depth understanding of HC Pharma’s manufacturing strength, quality control system and product technology advantages, while further discussing future strategic cooperation opportunities between the two parties.
As one of China’s leading professional manufacturers of veterinary pharmaceuticals and feed additives, HC Pharma has long been committed to providing systematic, efficient and safe nutritional and health solutions for global livestock and aquaculture industries. Relying on strong independent research and development capabilities and standardized large-scale production systems, the company has formed four core solution product matrices, including professional anti-coccidiosis solutions, high-efficiency antibacterial and anti-inflammatory solutions, comprehensive antiviral health solutions, and targeted growth and production performance improvement solutions. Its products are widely applied in poultry, livestock and aquaculture breeding, effectively helping breeding enterprises reduce disease risks, improve feed utilization efficiency and enhance overall breeding economic benefits.
During the inspection, Mr. Jakir Hossain was accompanied by HC Pharma’s technical and sales teams to tour the entire automated production workshop, raw material storage area, precision testing laboratory and finished product packaging workshop. The team comprehensively demonstrated the company’s standardized production processes, strict raw material screening standards, full-process quality monitoring systems and advanced intelligent production equipment. The on-site display of standardized production management, stable technological output capability and rigorous quality control system left a deep impression on the visiting delegation.
In the subsequent technical exchange and business negotiation session, the two sides conducted in-depth and detailed discussions on product technical parameters, international market application scenarios, product customization services and long-term cooperative development plans. Mr. Jakir Hossain fully recognized HC Pharma’s professional advantages in veterinary drug and feed additive research and development, stable product quality and mature industrial system. He affirmed the high practicability and market competitiveness of HC Pharma’s diversified breeding health solutions in solving common breeding pain points such as coccidiosis infection, bacterial and viral diseases, and slow growth of animals.
Both parties agreed that this on-site visit has further narrowed communication distance, deepened mutual trust and recognition, and laid a solid foundation for subsequent in-depth business docking and long-term stable strategic cooperation. In the future, the two sides will give full play to their respective resource and technical advantages, jointly expand overseas market channels, promote the output of high-quality Chinese animal health products, and create win-win development value for global breeding industry partners
